Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4415/ANN_20_03_14 http://scihub22266oqcxt.onion/10.4415/ANN_20_03_14 32959802!ä!32959802 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Ist+Super+Sanita 2020 ; 56 (3): 359-364 Nephropedia Template TP {{tp|p=32959802|t=2020. Bacterial coinfections in COVID-19: an underestimated adversary |pdf=|usr=}}{{32959802}} gab.com Text Bacterial coinfections in COVID-19: an underestimated adversary JO: Ann Ist Super Sanita http://www.kidney.de/pget.php?&tw=1&pmid=32959802 #FOAvip Current literature shows that secondary bacterial infections, although less frequent than in previous influenza pandemics, affect COVID-19 patients. Mycoplasma pneumoniae, Staphylococcus aureus, Legionella pneumophila, Streptococcus pneumoniae, Haemophilus and Klebsiella spp. are the main species isolated. Of note, Mycobacterium tuberculosis-COVID-19 coinfections are also reported. However, bacterial coinfection rates increase in patients admitted in the intensive care units, and those diseases can be due to super-infections by nosocomial antibiotic-resistant bacteria. This highlights the urgency to revise frequent and empiric prescription of broad-spectrum antibiotics in COVID-19 patients, with more attention to evidence-based studies and respect for the antimicrobial stewardship principles. Twit Text FOAVip Bacterial coinfections in COVID-19: an underestimated adversary ????Ann Ist Super Sanita http://www.kidney.de/pget.php?&tw=1&pmid=32959802 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32959802 #FOAvip English Wikipedia <ref>{{Cite pmid|32959802}}</ref> Bacterial coinfections in COVID-19: an underestimated adversary #MMPMID32959802 Fattorini L; Creti R; Palma C; Pantosti A Ann Ist Super Sanita 2020[Jul]; 56 (3): 359-364 PMID32959802show ga Current literature shows that secondary bacterial infections, although less frequent than in previous influenza pandemics, affect COVID-19 patients. Mycoplasma pneumoniae, Staphylococcus aureus, Legionella pneumophila, Streptococcus pneumoniae, Haemophilus and Klebsiella spp. are the main species isolated. Of note, Mycobacterium tuberculosis-COVID-19 coinfections are also reported. However, bacterial coinfection rates increase in patients admitted in the intensive care units, and those diseases can be due to super-infections by nosocomial antibiotic-resistant bacteria. This highlights the urgency to revise frequent and empiric prescription of broad-spectrum antibiotics in COVID-19 patients, with more attention to evidence-based studies and respect for the antimicrobial stewardship principles. |*Betacoronavirus[MESH] |*Pandemics[MESH] |Antimicrobial Stewardship[MESH] |Bacterial Infections/drug therapy/*epidemiology/microbiology/transmission[MESH] |COVID-19[MESH] |Coinfection/*epidemiology[MESH] |Coronavirus Infections/*epidemiology[MESH] |Cross Infection/epidemiology/transmission[MESH] |Drug Resistance, Microbial[MESH] |Early Diagnosis[MESH] |Humans[MESH] |Intensive Care Units[MESH] |Italy/epidemiology[MESH] |Mycoses/epidemiology[MESH] |Pneumonia, Viral/*epidemiology[MESH] |Respiratory Tract Infections/epidemiology/microbiology[MESH] |SARS-CoV-2[MESH] |Species Specificity[MESH]Bacterial coinfections in COVID-19: an underestimated adversary (epmc).pdf DeepDyve Pubget Overpricing